-
1
-
-
77953666447
-
Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development
-
London, England
-
Quinlan J, Gaydos B, Maca J, Krams M (2010) Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development. Clinical trials (London, England) 7: 167-173. doi:10.1177/1740774510361542
-
(2010)
Clinical Trials
, vol.7
, pp. 167-173
-
-
Quinlan, J.1
Gaydos, B.2
Maca, J.3
Krams, M.4
-
2
-
-
33846243782
-
A 25-year review of sequential methodology in clinical studies
-
PMID: 17139691
-
Todd S (2007) A 25-year review of sequential methodology in clinical studies. Statistics in medicine 26: 237-252. doi:10.1002/sim.2763 PMID: 17139691
-
(2007)
Statistics in Medicine
, vol.26
, pp. 237-252
-
-
Todd, S.1
-
4
-
-
84871838300
-
Overview, hurdles, and future work in adaptive designs: Perspectives from a National Institutes of Health-funded workshop
-
London, England
-
Coffey CS, Levin B, Clark C, Timmerman C, Wittes J, et al. (2012) Overview, hurdles, and future work in adaptive designs: perspectives from a National Institutes of Health-funded workshop. Clinical trials (London, England) 9: 671-680. doi:10.1177/1740774512461859
-
(2012)
Clinical Trials
, vol.9
, pp. 671-680
-
-
Coffey, C.S.1
Levin, B.2
Clark, C.3
Timmerman, C.4
Wittes, J.5
-
5
-
-
84865271518
-
Adaptive trial designs: A review of barriers and opportunities
-
PMID: 22917111
-
Kairalla J a, Coffey CS, Thomann M a, Muller KE (2012) Adaptive trial designs: a review of barriers and opportunities. Trials 13: 145. doi:10.1186/1745-6215-13-145 PMID: 22917111
-
(2012)
Trials
, vol.13
, pp. 145
-
-
Kairalla, J.A.1
Coffey, C.S.2
Thomann, M.A.3
Muller, K.E.4
-
6
-
-
84907946289
-
Adaptive clinical trial designs for European marketing authorization: A survey of scientific advice letters from the European Medicines Agency
-
PMID: 25278265
-
Elsäßer A, Regnstrom J, Vetter T, Koenig F, Hemmings RJ, et al. (2014) Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency. Trials 15: 383. doi:10.1186/1745-6215-15-383 PMID: 25278265
-
(2014)
Trials
, vol.15
, pp. 383
-
-
Elsäßer, A.1
Regnstrom, J.2
Vetter, T.3
Koenig, F.4
Hemmings, R.J.5
-
7
-
-
84903529904
-
Adaptive Design: Results of 2012 Survey on Perception and Use
-
Morgan CC, Huyck S, Jenkins M, Chen L, Bedding a., et al. (2014) Adaptive Design: Results of 2012 Survey on Perception and Use. Therapeutic Innovation & Regulatory Science 48: 473-481.
-
(2014)
Therapeutic Innovation & Regulatory Science
, vol.48
, pp. 473-481
-
-
Morgan, C.C.1
Huyck, S.2
Jenkins, M.3
Chen, L.4
Bedding, A.5
-
8
-
-
33646243834
-
Adaptive design in clinical research: Issues, opportunities, and recommendations
-
discussion 311-312. PMID: 16724486
-
Chang M, Chow S-C, Pong A (2006) Adaptive design in clinical research: issues, opportunities, and recommendations. Journal of biopharmaceutical statistics 16: 299-309; discussion 311-312. doi:10.1080/10543400600609718 PMID: 16724486
-
(2006)
Journal of Biopharmaceutical Statistics
, vol.16
, pp. 299-309
-
-
Chang, M.1
Chow, S.-C.2
Pong, A.3
-
9
-
-
78249281982
-
FDA draft guidance on adaptive design clinical trials: Pfizer's perspective
-
PMID: 21058110
-
Chuang-Stein C, Beltangady M (2010) FDA draft guidance on adaptive design clinical trials: Pfizer's perspective. Journal of biopharmaceutical statistics 20: 1143-1149. doi:10.1080/10543406.2010.514456 PMID: 21058110
-
(2010)
Journal of Biopharmaceutical Statistics
, vol.20
, pp. 1143-1149
-
-
Chuang-Stein, C.1
Beltangady, M.2
-
10
-
-
70350139975
-
Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development
-
Gaydos B, Anderson KM, Berry D, Burnham N, Chuang-Stein C, et al. (2009) Good Practices for Adaptive Clinical Trials in Pharmaceutical Product Development. Therapeutic Innovation & Regulatory Science 43: 539-556.
-
(2009)
Therapeutic Innovation & Regulatory Science
, vol.43
, pp. 539-556
-
-
Gaydos, B.1
Anderson, K.M.2
Berry, D.3
Burnham, N.4
Chuang-Stein, C.5
-
11
-
-
78249264147
-
Understanding the FDA guidance on adaptive designs: Historical, legal, and statistical perspectives
-
PMID: 21058114
-
Liu Q, Chi GYH (2010) Understanding the FDA guidance on adaptive designs: historical, legal, and statistical perspectives. Journal of biopharmaceutical statistics 20: 1178-1219. doi:10.1080/10543406.2010.514462 PMID: 21058114
-
(2010)
Journal of Biopharmaceutical Statistics
, vol.20
, pp. 1178-1219
-
-
Liu, Q.1
Chi, G.Y.H.2
-
12
-
-
84899999885
-
Adaptive clinical trial design
-
PMID: 24422576
-
Chow S-C (2014) Adaptive clinical trial design. Annual review of medicine 65: 405-415. doi:10.1146/annurev-med-092012-112310 PMID: 24422576
-
(2014)
Annual Review of Medicine
, vol.65
, pp. 405-415
-
-
Chow, S.-C.1
-
13
-
-
44949171503
-
Adaptive design methods in clinical trials - A review
-
PMID: 18454853
-
Chow S-C, Chang M (2008) Adaptive design methods in clinical trials - a review. Orphanet journal of rare diseases 3: 11. doi:10.1186/1750-1172-3-11 PMID: 18454853
-
(2008)
Orphanet Journal of Rare Diseases
, vol.3
, pp. 11
-
-
Chow, S.-C.1
Chang, M.2
-
14
-
-
33750893179
-
Implementing adaptive designs: Logistical and operational considerations
-
Quinlan J, Krams M (2006) Implementing adaptive designs: logistical and operational considerations. Drug Information Journal 40: 437-444.
-
(2006)
Drug Information Journal
, vol.40
, pp. 437-444
-
-
Quinlan, J.1
Krams, M.2
-
15
-
-
84942308496
-
Missing steps in a staircase: A qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials
-
PMID: 26416387
-
Dimairo M, Boote J, Julious SA, Nicholl JP, Todd S (2015) Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials. Trials 16: 430. doi:10.1186/s13063-015-0958-9 PMID: 26416387
-
(2015)
Trials
, vol.16
, pp. 430
-
-
Dimairo, M.1
Boote, J.2
Julious, S.A.3
Nicholl, J.P.4
Todd, S.5
-
16
-
-
9444255722
-
Improving the quality of reporting of randomized controlled trials. The CONSORT statement
-
PMID: 8773637
-
Begg C, Cho M, Eastwood S, Horton R, Moher D, et al. (1996) Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276: 637-639. PMID: 8773637
-
(1996)
JAMA
, vol.276
, pp. 637-639
-
-
Begg, C.1
Cho, M.2
Eastwood, S.3
Horton, R.4
Moher, D.5
-
17
-
-
77953395873
-
CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials
-
PMID: 20335313
-
Schulz KF, Altman DG, Moher D (2010) CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Annals of internal medicine 152: 726-732. doi:10.7326/0003-4819-152-11-201006010-00232 PMID: 20335313
-
(2010)
Annals of Internal Medicine
, vol.152
, pp. 726-732
-
-
Schulz, K.F.1
Altman, D.G.2
Moher, D.3
-
18
-
-
0035857966
-
The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials
-
PMID: 11323066
-
Moher D, Schulz KF, Altman DG (2001) The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357: 1191-1194. PMID: 11323066
-
(2001)
Lancet
, vol.357
, pp. 1191-1194
-
-
Moher, D.1
Schulz, K.F.2
Altman, D.G.3
-
19
-
-
0035906301
-
Value of flow diagrams in reports of randomized controlled trials
-
PMID: 11308437
-
Egger M, Jüni P, Bartlett C (2001) Value of flow diagrams in reports of randomized controlled trials. JAMA 285: 1996-1999. PMID: 11308437
-
(2001)
JAMA
, vol.285
, pp. 1996-1999
-
-
Egger, M.1
Jüni, P.2
Bartlett, C.3
-
20
-
-
0035906286
-
Use of the CONSORT Statement and Quality of Reports of Randomized Trials
-
PMID: 11308436
-
Moher D, Jones A, Lepage L (2001) Use of the CONSORT Statement and Quality of Reports of Randomized Trials. JAMA 285: 1992. doi:10.1001/jama.285.15.1992 PMID: 11308436
-
(2001)
JAMA
, vol.285
, pp. 1992
-
-
Moher, D.1
Jones, A.2
Lepage, L.3
-
21
-
-
84872084158
-
Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review
-
PMID: 23194585
-
Turner L, Shamseer L, Altman DG, Schulz KF, Moher D (2012) Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review. Systematic reviews 1: 60. doi:10.1186/2046-4053-1-60 PMID: 23194585
-
(2012)
Systematic Reviews
, vol.1
, pp. 60
-
-
Turner, L.1
Shamseer, L.2
Altman, D.G.3
Schulz, K.F.4
Moher, D.5
-
22
-
-
84867482934
-
Improving the reporting of randomised trials: The CONSORT Statement and beyond
-
PMID: 22903776
-
Altman DG, Moher D, Schulz KF (2012) Improving the reporting of randomised trials: the CONSORT Statement and beyond. Statistics in medicine 31: 2985-2997. doi:10.1002/sim.5402 PMID: 22903776
-
(2012)
Statistics in Medicine
, vol.31
, pp. 2985-2997
-
-
Altman, D.G.1
Moher, D.2
Schulz, K.F.3
-
23
-
-
84868325759
-
Consort 2010 statement: Extension to cluster randomised trials
-
Clinical research ed
-
Campbell MK, Piaggio G, Elbourne DR, Altman DG (2012) Consort 2010 statement: extension to cluster randomised trials. BMJ (Clinical research ed) 345: e5661. doi:10.1136/bmj.e5661
-
(2012)
BMJ
, vol.345
-
-
Campbell, M.K.1
Piaggio, G.2
Elbourne, D.R.3
Altman, D.G.4
-
24
-
-
84871484789
-
Reporting of noninferiority and equivalence randomized trials: Extension of the CONSORT 2010 statement
-
PMID: 23268518
-
Piaggio G, Elbourne DR, Pocock SJ, Evans SJW, Altman DG (2012) Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA 308: 2594-2604. doi:10.1001/jama.2012.87802 PMID: 23268518
-
(2012)
JAMA
, vol.308
, pp. 2594-2604
-
-
Piaggio, G.1
Elbourne, D.R.2
Pocock, S.J.3
Evans, S.J.W.4
Altman, D.G.5
-
25
-
-
57349108691
-
Improving the reporting of pragmatic trials: An extension of the CONSORT statement
-
Clinical research ed
-
Zwarenstein M, Treweek S, Gagnier JJ, Altman DG, Tunis S, et al. (2008) Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ (Clinical research ed) 337: a2390. doi:10.1136/bmj.a2390
-
(2008)
BMJ
, vol.337
-
-
Zwarenstein, M.1
Treweek, S.2
Gagnier, J.J.3
Altman, D.G.4
Tunis, S.5
-
27
-
-
84889644506
-
-
Detry M, Lewis R, Broglio K, Connor J (2012) Standards for the Design, Conduct, and Evaluation of Adaptive Randomized Clinical Trials.
-
(2012)
Standards for the Design, Conduct, and Evaluation of Adaptive Randomized Clinical Trials
-
-
Detry, M.1
Lewis, R.2
Broglio, K.3
Connor, J.4
-
29
-
-
84951161407
-
-
(n.d.) ClinicalTrials.gov. Accessed 1 June 2014
-
U.S. National Institutes of Health (n.d.) ClinicalTrials.gov. Available: https://clinicaltrials.gov/.Accessed 1 June 2014.
-
-
-
U.S. National Institutes of Health1
-
30
-
-
84907260902
-
Study flow diagrams in Cochrane systematic review updates: An adapted PRISMA flow diagram
-
PMID: 24886533
-
Stovold E, Beecher D, Foxlee R, Noel-Storr A (2014) Study flow diagrams in Cochrane systematic review updates: an adapted PRISMA flow diagram. Systematic reviews 3: 54. doi:10.1186/2046-4053-3-54 PMID: 24886533
-
(2014)
Systematic Reviews
, vol.3
, pp. 54
-
-
Stovold, E.1
Beecher, D.2
Foxlee, R.3
Noel-Storr, A.4
-
31
-
-
68049122102
-
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
-
PMID: 19621072
-
Moher D, Liberati A, Tetzlaff J, Altman DG (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine 6: e1000097. doi:10.1371/journal.pmed.1000097 PMID: 19621072
-
(2009)
PLoS Medicine
, vol.6
-
-
Moher, D.1
Liberati, A.2
Tetzlaff, J.3
Altman, D.G.4
-
32
-
-
0032580320
-
Two-sided confidence intervals for the single proportion: Comparison of seven methods
-
PMID: 9595616
-
Newcombe RG (1998) Two-sided confidence intervals for the single proportion: Comparison of seven methods. Statistics in Medicine 17: 857-872. doi:10.1002/(SICI)1097-0258(19980430)17:8〈857::AID-SIM777〉3.0.CO;2-E PMID: 9595616
-
(1998)
Statistics in Medicine
, vol.17
, pp. 857-872
-
-
Newcombe, R.G.1
-
33
-
-
0002344794
-
Bootstrap Methods: Another Look at the Jackknife
-
Efron B (1979) Bootstrap Methods: Another Look at the Jackknife. The Annals of Statistics 7: 1-26.
-
(1979)
The Annals of Statistics
, vol.7
, pp. 1-26
-
-
Efron, B.1
-
34
-
-
70449529019
-
Discrete sequential boundaries for clinical trials
-
Lan K, DeMets D (1983) Discrete sequential boundaries for clinical trials. Biometrika 70: 659-663.
-
(1983)
Biometrika
, vol.70
, pp. 659-663
-
-
Lan, K.1
DeMets, D.2
-
35
-
-
0018687930
-
A multiple testing procedure for clinical trials
-
PMID: 497341
-
O'Brien P, Fleming T (1979) A multiple testing procedure for clinical trials. Biometrics 35: 549-556. PMID: 497341
-
(1979)
Biometrics
, vol.35
, pp. 549-556
-
-
O'Brien, P.1
Fleming, T.2
-
36
-
-
0017744944
-
Group Sequential Methods in the Design and Analysis of Clinical Trials
-
Pocock SJ (1977) Group Sequential Methods in the Design and Analysis of Clinical Trials. Biometrika 64: 191. doi:10.2307/2335684
-
(1977)
Biometrika
, vol.64
, pp. 191
-
-
Pocock, S.J.1
-
37
-
-
0015131639
-
Repeated assessment of results in clinical trials of cancer treatment
-
PMID: 4940475
-
Haybittle J (1971) Repeated assessment of results in clinical trials of cancer treatment. The British journal of radiology 44: 793-797. PMID: 4940475
-
(1971)
The British Journal of Radiology
, vol.44
, pp. 793-797
-
-
Haybittle, J.1
-
38
-
-
0017365573
-
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
-
PMID: 831755
-
Peto R, Pike MC, Armitage P, Breslow NE, Cox DR, et al. (1977) Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. British journal of cancer 35: 1-39. PMID: 831755
-
(1977)
British Journal of Cancer
, vol.35
, pp. 1-39
-
-
Peto, R.1
Pike, M.C.2
Armitage, P.3
Breslow, N.E.4
Cox, D.R.5
-
39
-
-
0002296743
-
Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis
-
Pampallona S, Tsiatis A a. (1994) Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis. Journal of Statistical Planning and Inference 42: 19-35. doi:10.1016/0378-3758(94)90187-2
-
(1994)
Journal of Statistical Planning and Inference
, vol.42
, pp. 19-35
-
-
Pampallona, S.1
Tsiatis, A.A.2
-
40
-
-
0025598008
-
Group sequential designs using a family of type I error probability spending functions
-
PMID: 2281231
-
Hwang IK, Shih WJ, De Cani JS (1990) Group sequential designs using a family of type I error probability spending functions. Statistics in medicine 9: 1439-1445. PMID: 2281231
-
(1990)
Statistics in Medicine
, vol.9
, pp. 1439-1445
-
-
Hwang, I.K.1
Shih, W.J.2
De Cani, J.S.3
-
42
-
-
0023217456
-
Approximately optimal one-parameter boundaries for group sequential trials
-
PMID: 3567304
-
Wang S, Tsiatis A (1987) Approximately optimal one-parameter boundaries for group sequential trials. Biometrics 43: 193-199. PMID: 3567304
-
(1987)
Biometrics
, vol.43
, pp. 193-199
-
-
Wang, S.1
Tsiatis, A.2
-
43
-
-
0020108590
-
One-sample multiple testing procedure for phase II clinical trials
-
PMID: 7082756
-
Fleming TR (1982) One-sample multiple testing procedure for phase II clinical trials. Biometrics 38: 143-151. PMID: 7082756
-
(1982)
Biometrics
, vol.38
, pp. 143-151
-
-
Fleming, T.R.1
-
44
-
-
0033619169
-
A unified theory for sequential clinical trials
-
PMID: 10474138
-
Whitehead J A unified theory for sequential clinical trials. Statistics in medicine 18: 2271-2286. PMID: 10474138
-
Statistics in Medicine
, vol.18
, pp. 2271-2286
-
-
Whitehead, J.1
-
45
-
-
84888015440
-
Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: A randomised clinical trial on overall survival
-
Oxford, England
-
Tröger W, Galun D, Reif M, Schumann A, Stanković N, et al. (2013) Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival. European journal of cancer (Oxford, England: 1990) 49: 3788-3797. doi:10.1016/j.ejca.2013.06.043
-
(1990)
European Journal of Cancer
, vol.49
, pp. 3788-3797
-
-
Tröger, W.1
Galun, D.2
Reif, M.3
Schumann, A.4
Stanković, N.5
-
46
-
-
84891373760
-
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): A randomised, double-blind, phase 3 trial
-
PMID: 24331154
-
Butts C, Socinski M a, Mitchell PL, Thatcher N, Havel L, et al. (2014) Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial. The Lancet Oncology 15: 59-68. doi:10.1016/S1470-2045(13)70510-2 PMID: 24331154
-
(2014)
The Lancet Oncology
, vol.15
, pp. 59-68
-
-
Butts, C.1
Socinski, M.A.2
Mitchell, P.L.3
Thatcher, N.4
Havel, L.5
-
47
-
-
84903527674
-
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): An open-label, randomised, phase 3 trial
-
PMID: 24954781
-
Middleton G, Silcocks P, Cox T, Valle J, Wadsley J, et al. (2014) Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial. The Lancet Oncology 15: 829-840. doi:10.1016/S1470-2045(14)70236-0 PMID: 24954781
-
(2014)
The Lancet Oncology
, vol.15
, pp. 829-840
-
-
Middleton, G.1
Silcocks, P.2
Cox, T.3
Valle, J.4
Wadsley, J.5
-
48
-
-
79959252941
-
The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease
-
London, England
-
Pritchett Y, Jemiai Y, Chang Y, Bhan I, Agarwal R, et al. (2011) The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease. Clinical trials (London, England) 8: 165-174. doi:10.1177/1740774511399128
-
(2011)
Clinical Trials
, vol.8
, pp. 165-174
-
-
Pritchett, Y.1
Jemiai, Y.2
Chang, Y.3
Bhan, I.4
Agarwal, R.5
-
49
-
-
84951026282
-
-
02114
-
Thadhani R, Wenger J, Tamez H, Cannata J, Thompson BT, et al. (2012) Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease. 02114.
-
(2012)
Vitamin D Therapy and Cardiac Structure and Function in Patients with Chronic Kidney Disease
-
-
Thadhani, R.1
Wenger, J.2
Tamez, H.3
Cannata, J.4
Thompson, B.T.5
-
50
-
-
84872518645
-
Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer
-
Wolff AC, Lazar AA, Bondarenko I, Garin AM, Brincat S, et al. (2013) Randomized phase III placebo-controlled trial of letrozole plus oral temsirolimus as first-line endocrine therapy in postmenopausal women with locally advanced or metastatic breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 31: 195-202. doi:10.1200/JCO.2011.38.3331
-
(2013)
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
, vol.31
, pp. 195-202
-
-
Wolff, A.C.1
Lazar, A.A.2
Bondarenko, I.3
Garin, A.M.4
Brincat, S.5
-
51
-
-
84864512253
-
Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer
-
PMID: 22853014
-
Mehta RS, Barlow WE, Albain KS, Vandenberg T a, Dakhil SR, et al. (2012) Combination Anastrozole and Fulvestrant in Metastatic Breast Cancer. The New England journal of medicine 367: 435-444. doi:10.1056/NEJMoa1201622 PMID: 22853014
-
(2012)
The New England Journal of Medicine
, vol.367
, pp. 435-444
-
-
Mehta, R.S.1
Barlow, W.E.2
Albain, K.S.3
Vandenberg, T.A.4
Dakhil, S.R.5
-
52
-
-
84893439058
-
Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study
-
PMID: 24211172
-
Chew EY, Clemons TE, Bressler SB, Elman MJ, Danis RP, et al. (2014) Randomized trial of a home monitoring system for early detection of choroidal neovascularization home monitoring of the Eye (HOME) study. Ophthalmology 121: 535-544. doi:10.1016/j.ophtha.2013.10.027 PMID: 24211172
-
(2014)
Ophthalmology
, vol.121
, pp. 535-544
-
-
Chew, E.Y.1
Clemons, T.E.2
Bressler, S.B.3
Elman, M.J.4
Danis, R.P.5
-
53
-
-
0001136460
-
Parameter estimation following group sequential hypothesis testing
-
Emerson S, Fleming T (1990) Parameter estimation following group sequential hypothesis testing. Biometrika 77: 875-892.
-
(1990)
Biometrika
, vol.77
, pp. 875-892
-
-
Emerson, S.1
Fleming, T.2
-
54
-
-
78650183501
-
Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: A randomized controlled trial
-
PMID: 21156950
-
Mascia L, Pasero D, Slutsky AS, Arguis MJ, Berardino M, et al. (2010) Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA 304: 2620-2627. doi:10.1001/jama.2010.1796 PMID: 21156950
-
(2010)
JAMA
, vol.304
, pp. 2620-2627
-
-
Mascia, L.1
Pasero, D.2
Slutsky, A.S.3
Arguis, M.J.4
Berardino, M.5
-
55
-
-
0141688333
-
Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group
-
Moore MJ, Hamm J, Dancey J, Eisenberg PD, Dagenais M, et al. (2003) Comparison of gemcitabine versus the matrix metalloproteinase inhibitor BAY 12-9566 in patients with advanced or metastatic adenocarcinoma of the pancreas: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 21: 3296-3302. doi:10.1200/JCO.2003.02.098
-
(2003)
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
, vol.21
, pp. 3296-3302
-
-
Moore, M.J.1
Hamm, J.2
Dancey, J.3
Eisenberg, P.D.4
Dagenais, M.5
-
56
-
-
0038690538
-
Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group trial
-
Markman M, Liu PY, Wilczynski S, Monk B, Copeland LJ, et al. (2003) Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a Southwest Oncology Group and Gynecologic Oncology Group trial. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 21: 2460-2465. doi:10.1200/JCO.2003.07.013
-
(2003)
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology
, vol.21
, pp. 2460-2465
-
-
Markman, M.1
Liu, P.Y.2
Wilczynski, S.3
Monk, B.4
Copeland, L.J.5
-
57
-
-
84987922666
-
The reporting quality of parallel randomised controlled trials in ophthalmic surgery in 2011: A systematic review
-
London, England
-
Yao AC, Khajuria A, Camm CF, Edison E, Agha R (2014) The reporting quality of parallel randomised controlled trials in ophthalmic surgery in 2011: a systematic review. Eye (London, England) 28: 1341-1349. doi:10.1038/eye.2014.206
-
(2014)
Eye
, vol.28
, pp. 1341-1349
-
-
Yao, A.C.1
Khajuria, A.2
Camm, C.F.3
Edison, E.4
Agha, R.5
-
58
-
-
79959754366
-
Quality of reporting randomised controlled trials in major dental journals suboptimal
-
PMID: 21701551
-
Hurst D (2011) Quality of reporting randomised controlled trials in major dental journals suboptimal. Evidence-based dentistry 12: 52-53. doi:10.1038/sj.ebd.6400796 PMID: 21701551
-
(2011)
Evidence-Based Dentistry
, vol.12
, pp. 52-53
-
-
Hurst, D.1
-
59
-
-
0037176688
-
Quality of reporting randomised clinical trials in dental and medical research
-
PMID: 11838001
-
Sjögren P, Halling A (2002) Quality of reporting randomised clinical trials in dental and medical research. British dental journal 192: 100-103. doi:10.1038/sj.bdj.4801304a PMID: 11838001
-
(2002)
British Dental Journal
, vol.192
, pp. 100-103
-
-
Sjögren, P.1
Halling, A.2
-
60
-
-
84885321870
-
An assessment of the reporting quality of randomised controlled trials relating to anti-arrhythmic agents (2002-2011)
-
PMID: 23298560
-
Camm CF, Chen Y, Sunderland N, Nagendran M, Maruthappu M, et al. (2013) An assessment of the reporting quality of randomised controlled trials relating to anti-arrhythmic agents (2002-2011). International journal of cardiology 168: 1393-1396. doi:10.1016/j.ijcard.2012.12.020 PMID: 23298560
-
(2013)
International Journal of Cardiology
, vol.168
, pp. 1393-1396
-
-
Camm, C.F.1
Chen, Y.2
Sunderland, N.3
Nagendran, M.4
Maruthappu, M.5
-
61
-
-
84862807351
-
Published methodological quality of randomized controlled trials does not reflect the actual quality assessed in protocols
-
PMID: 22424985
-
Mhaskar R, Djulbegovic B, Magazin A, Soares HP, Kumar A (2012) Published methodological quality of randomized controlled trials does not reflect the actual quality assessed in protocols. Journal of clinical epidemiology 65: 602-609. doi:10.1016/j.jclinepi.2011.10.016 PMID: 22424985
-
(2012)
Journal of Clinical Epidemiology
, vol.65
, pp. 602-609
-
-
Mhaskar, R.1
Djulbegovic, B.2
Magazin, A.3
Soares, H.P.4
Kumar, A.5
-
62
-
-
27644487803
-
Randomized trials stopped early for benefit: A systematic review
-
PMID: 16264162
-
Montori VM, Devereaux PJ, Adhikari NKJ, Burns KEA, Eggert CH, et al. (2005) Randomized trials stopped early for benefit: a systematic review. JAMA 294: 2203-2209. doi:10.1001/jama.294.17.2203 PMID: 16264162
-
(2005)
JAMA
, vol.294
, pp. 2203-2209
-
-
Montori, V.M.1
Devereaux, P.J.2
Adhikari, N.K.J.3
Burns, K.E.A.4
Eggert, C.H.5
-
63
-
-
38349177944
-
Early stopping of randomized clinical trials for overt efficacy is problematic
-
PMID: 18226746
-
Bassler D, Montori VM, Briel M, Glasziou P, Guyatt G (2008) Early stopping of randomized clinical trials for overt efficacy is problematic. Journal of clinical epidemiology 61: 241-246. doi:10.1016/j.jclinepi.2007.07.016 PMID: 18226746
-
(2008)
Journal of Clinical Epidemiology
, vol.61
, pp. 241-246
-
-
Bassler, D.1
Montori, V.M.2
Briel, M.3
Glasziou, P.4
Guyatt, G.5
-
64
-
-
77949879943
-
Stopping randomized trials early for benefit and estimation of treatment effects: Systematic review and meta-regression analysis
-
PMID: 20332404
-
Bassler D, Briel M, Montori VM, Lane M, Glasziou P, et al. (2010) Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta-regression analysis. JAMA 303: 1180-1187. doi:10.1001/jama.2010.310 PMID: 20332404
-
(2010)
JAMA
, vol.303
, pp. 1180-1187
-
-
Bassler, D.1
Briel, M.2
Montori, V.M.3
Lane, M.4
Glasziou, P.5
-
65
-
-
84925286107
-
Are We There Yet? Early Stopping in Clinical Trials
-
PMID: 25601251
-
Wears RL (2015) Are We There Yet? Early Stopping in Clinical Trials. Annals of Emergency Medicine 65: 214-215. doi:10.1016/j.annemergmed.2014.12.020 PMID: 25601251
-
(2015)
Annals of Emergency Medicine
, vol.65
, pp. 214-215
-
-
Wears, R.L.1
-
66
-
-
84866389504
-
Overestimation of the effect size in group sequential trials
-
Zhang JJ, Blumenthal GM, He K, Tang S, Cortazar P, et al. (2012) Overestimation of the effect size in group sequential trials. Clinical cancer research: an official journal of the American Association for Cancer Research 18: 4872-4876. doi:10.1158/1078-0432.CCR-11-3118
-
(2012)
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research
, vol.18
, pp. 4872-4876
-
-
Zhang, J.J.1
Blumenthal, G.M.2
He, K.3
Tang, S.4
Cortazar, P.5
-
67
-
-
84871849094
-
Stopping a trial early - And then what?
-
London, England
-
Wittes J (2012) Stopping a trial early - and then what? Clinical trials (London, England) 9: 714-720. doi:10.1177/1740774512454600
-
(2012)
Clinical Trials
, vol.9
, pp. 714-720
-
-
Wittes, J.1
-
68
-
-
84860803495
-
When to stop a clinical trial early for benefit: Lessons learned and future approaches
-
PMID: 22438522
-
Zannad F, Stough WG, McMurray JJ V, Remme WJ, Pitt B, et al. (2012) When to stop a clinical trial early for benefit: Lessons learned and future approaches. Circulation: Heart Failure 5: 294-302. doi:10.1161/CIRCHEARTFAILURE.111.965707 PMID: 22438522
-
(2012)
Circulation: Heart Failure
, vol.5
, pp. 294-302
-
-
Zannad, F.1
Stough, W.G.2
McMurray, J.J.V.3
Remme, W.J.4
Pitt, B.5
-
69
-
-
65249135552
-
Stopping clinical trials early for benefit: Impact on estimation
-
London, England
-
Freidlin B, Korn EL (2009) Stopping clinical trials early for benefit: impact on estimation. Clinical trials (London, England) 6: 119-125. doi:10.1177/1740774509102310
-
(2009)
Clinical Trials
, vol.6
, pp. 119-125
-
-
Freidlin, B.1
Korn, E.L.2
-
70
-
-
0024347637
-
Point estimation following group sequential tests
-
PMID: 2765641
-
Kim K (1989) Point estimation following group sequential tests. Biometrics 45: 613-617. PMID: 2765641
-
(1989)
Biometrics
, vol.45
, pp. 613-617
-
-
Kim, K.1
-
71
-
-
0001348868
-
Point and interval estimation following a sequential clinical trial
-
Todd S, Whitehead J, Facey K (1996) Point and interval estimation following a sequential clinical trial. Biometrika 83: 453-461.
-
(1996)
Biometrika
, vol.83
, pp. 453-461
-
-
Todd, S.1
Whitehead, J.2
Facey, K.3
-
72
-
-
0000949287
-
Unbiased estimation following a group sequential test
-
Liu A, Hall W (1999) Unbiased estimation following a group sequential test. Biometrika 86: 71-78.
-
(1999)
Biometrika
, vol.86
, pp. 71-78
-
-
Liu, A.1
Hall, W.2
-
73
-
-
0001547530
-
On the bias of maximum likelihood estimation following a sequential test
-
Whitehead J (1986) On the bias of maximum likelihood estimation following a sequential test. Biometrika 73: 573-581.
-
(1986)
Biometrika
, vol.73
, pp. 573-581
-
-
Whitehead, J.1
-
74
-
-
0027402599
-
Computation of the uniform minimum variance unbiased estimator of a normal mean following a group sequential trial
-
PMID: 8444028
-
Emerson SS (1993) Computation of the uniform minimum variance unbiased estimator of a normal mean following a group sequential trial. Computers and biomedical research, an international journal 26: 68-73. PMID: 8444028
-
(1993)
Computers and Biomedical Research, An International Journal
, vol.26
, pp. 68-73
-
-
Emerson, S.S.1
-
75
-
-
0030899910
-
A computationally simpler algorithm for the UMVUE of a normal mean following a group sequential trial
-
PMID: 9147601
-
Emerson S, Kittelson J (1997) A computationally simpler algorithm for the UMVUE of a normal mean following a group sequential trial. Biometrics 53: 365-369. PMID: 9147601
-
(1997)
Biometrics
, vol.53
, pp. 365-369
-
-
Emerson, S.1
Kittelson, J.2
-
76
-
-
85018092133
-
Estimation After a Group Sequential Trial
-
Milanzi E, Molenberghs G, Alonso A, Kenward MG, Tsiatis AA, et al. (2014) Estimation After a Group Sequential Trial. Statistics in Biosciences.
-
(2014)
Statistics in Biosciences
-
-
Milanzi, E.1
Molenberghs, G.2
Alonso, A.3
Kenward, M.G.4
Tsiatis, A.A.5
-
77
-
-
82255169270
-
Benefits, challenges and obstacles of adaptive clinical trial designs
-
PMID: 22129361
-
Chow S-C, Corey R (2011) Benefits, challenges and obstacles of adaptive clinical trial designs. Orphanet journal of rare diseases 6: 79. doi:10.1186/1750-1172-6-79 PMID: 22129361
-
(2011)
Orphanet Journal of Rare Diseases
, vol.6
, pp. 79
-
-
Chow, S.-C.1
Corey, R.2
-
78
-
-
84892575232
-
Reducing waste from incomplete or unusable reports of biomedical research
-
PMID: 24411647
-
Glasziou P, Altman DG, Bossuyt P, Boutron I, Clarke M, et al. (2014) Reducing waste from incomplete or unusable reports of biomedical research. Lancet 383: 267-276. doi:10.1016/S0140-6736(13)62228-X PMID: 24411647
-
(2014)
Lancet
, vol.383
, pp. 267-276
-
-
Glasziou, P.1
Altman, D.G.2
Bossuyt, P.3
Boutron, I.4
Clarke, M.5
|